312 related articles for article (PubMed ID: 8765816)
1. The value of an in-hospital insect sting challenge as a criterion for application or omission of venom immunotherapy.
Blaauw PJ; Smithuis OL; Elbers AR
J Allergy Clin Immunol; 1996 Jul; 98(1):39-47. PubMed ID: 8765816
[TBL] [Abstract][Full Text] [Related]
2. Maintenance venom immunotherapy administered at 3-month intervals is both safe and efficacious.
Goldberg A; Confino-Cohen R
J Allergy Clin Immunol; 2001 May; 107(5):902-6. PubMed ID: 11344360
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety.
Müller U; Helbling A; Berchtold E
J Allergy Clin Immunol; 1992 Feb; 89(2):529-35. PubMed ID: 1740583
[TBL] [Abstract][Full Text] [Related]
4. Rush Hymenoptera venom immunotherapy: a safe and practical protocol for high-risk patients.
Sturm G; Kränke B; Rudolph C; Aberer W
J Allergy Clin Immunol; 2002 Dec; 110(6):928-33. PubMed ID: 12464961
[TBL] [Abstract][Full Text] [Related]
5. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses.
Ruëff F; Wenderoth A; Przybilla B
J Allergy Clin Immunol; 2001 Dec; 108(6):1027-32. PubMed ID: 11742283
[TBL] [Abstract][Full Text] [Related]
6. Risk assessment of Hymenoptera re-sting frequency: implications for decision-making in venom immunotherapy.
von Moos S; Graf N; Johansen P; Müllner G; Kündig TM; Senti G
Int Arch Allergy Immunol; 2013; 160(1):86-92. PubMed ID: 22948338
[TBL] [Abstract][Full Text] [Related]
7. [Wasp and bee venom allergy].
Knulst AC; de Maat-Bleeker F; Bruijnzeel-Koomen CA
Ned Tijdschr Geneeskd; 1998 Apr; 142(16):889-92. PubMed ID: 9623183
[TBL] [Abstract][Full Text] [Related]
8. Venom immunotherapy for preventing allergic reactions to insect stings.
Boyle RJ; Elremeli M; Hockenhull J; Cherry MG; Bulsara MK; Daniels M; Oude Elberink JN
Cochrane Database Syst Rev; 2012 Oct; 10(10):CD008838. PubMed ID: 23076950
[TBL] [Abstract][Full Text] [Related]
9. Stinging insect allergy: natural history and modification with venom immunotherapy.
Reisman RE; Dvorin DJ; Randolph CC; Georgitis JW
J Allergy Clin Immunol; 1985 Jun; 75(6):735-40. PubMed ID: 4008803
[TBL] [Abstract][Full Text] [Related]
10. Discontinuation of yellow jacket venom immunotherapy: follow-up of 75 patients by means of deliberate sting challenge.
van Halteren HK; van der Linden PW; Burgers JA; Bartelink AK
J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 1):767-70. PubMed ID: 9438484
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the allergenicity and antigenicity of yellow jacket and hornet venoms.
Reisman RE; Mueller U; Wypych J; Elliott W; Arbesman CE
J Allergy Clin Immunol; 1982 Mar; 69(3):268-74. PubMed ID: 6801104
[TBL] [Abstract][Full Text] [Related]
12. Clinical correlation of the venom-specific IgG antibody level during maintenance venom immunotherapy.
Golden DB; Lawrence ID; Hamilton RH; Kagey-Sobotka A; Valentine MD; Lichtenstein LM
J Allergy Clin Immunol; 1992 Sep; 90(3 Pt 1):386-93. PubMed ID: 1527321
[TBL] [Abstract][Full Text] [Related]
13. The evaluation of the common diagnostic methods of hypersensitivity for bee and yellow jacket venom by means of an in-hospital insect sting.
Blaauw PJ; Smithuis LO
J Allergy Clin Immunol; 1985 May; 75(5):556-62. PubMed ID: 3989140
[TBL] [Abstract][Full Text] [Related]
14. Long-term efficacy of venom immunotherapy.
Hafner T; DuBuske L; Kosnik M
Ann Allergy Asthma Immunol; 2008 Feb; 100(2):162-5. PubMed ID: 18320918
[TBL] [Abstract][Full Text] [Related]
15. The sting challenge test in Hymenoptera venom allergy: pros and cons.
Bilò MB; Brianzoni MF; Garritani MS; Antonicelli L; Farabollini B; Bonifazi F
Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):377-81. PubMed ID: 14768522
[TBL] [Abstract][Full Text] [Related]
16. The value of immunotherapy with venom in children with allergy to insect stings.
Valentine MD; Schuberth KC; Kagey-Sobotka A; Graft DF; Kwiterovich KA; Szklo M; Lichtenstein LM
N Engl J Med; 1990 Dec; 323(23):1601-3. PubMed ID: 2098016
[TBL] [Abstract][Full Text] [Related]
17. Rush hymenoptera venom immunotherapy is efficacious and safe.
Pasaoglu G; Sin BA; Misirligil Z
J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
[TBL] [Abstract][Full Text] [Related]
18. The VISYT trial: Venom Immunotherapy Safety and Tolerability with purified vs nonpurified extracts.
Bilò MB; Severino M; Cilia M; Pio A; Casino G; Ferrarini E; Campodonico P; Milani M
Ann Allergy Asthma Immunol; 2009 Jul; 103(1):57-61. PubMed ID: 19663128
[TBL] [Abstract][Full Text] [Related]
19. Safety of specific immunotherapy using a four-hour ultra-rush induction scheme in bee and wasp allergy.
Roll A; Hofbauer G; Ballmer-Weber BK; Schmid-Grendelmeier P
J Investig Allergol Clin Immunol; 2006; 16(2):79-85. PubMed ID: 16689180
[TBL] [Abstract][Full Text] [Related]
20. Adverse reactions to venom immunotherapy.
Ramirez DA; Londono S; Evans R
Ann Allergy; 1981 Dec; 47(6):435-9. PubMed ID: 7325415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
